Canadian Hospital Specialties welcomes Flexpoint Ford as strategic investor
On April 22, 2021, Canadian Hospital Specialties Ltd. ("CHS") announced it received a strategic investment from Flexpoint Ford ("Flexpoint").
Previously majority-owned by affiliates of Cortec Group, CHS will continue operating as an independent company led by CEO Mike Canzoneri and the company's current management team, who will continue to be owners in the business.
Further information can be found on Canada Newswire’s website.
CHS is a leading specialty distributor and manufacturer of medical and surgical products, serving customers in the acute care and alternate site healthcare sectors throughout Canada and internationally. It provides single-use and other medical products supplied by global medical device manufacturers as well as its own manufactured products, which are marketed under the proprietary MED-RX® brand, across categories including Respiratory, Anesthesia, Perfusion, Interventional, Biopsy, Drainage, Diagnostic Imaging, Pharmacy, Medication Delivery, Neonatal Care, OEM and General Medical.
Flexpoint Ford is a private equity investment firm that has raised more than US$4.8 billion in capital and specializes in privately negotiated investments in the financial services and healthcare industries.